86 related articles for article (PubMed ID: 21993176)
1. [Muscle catabolism in patients with chronic obstructive pulmonary disease].
Montenegro Álvarez de Tejera P; Cabanes-Mariscal MA; Gutiérrez-Ortega C; Medina Font J; Villa-Corbatón MC; Gómez de Terreros J
Rev Clin Esp; 2011 Nov; 211(10):511-6. PubMed ID: 21993176
[TBL] [Abstract][Full Text] [Related]
2. COPD, chronic bronchitis and capacity for day-to-day activities: negative impact of illness on the health-related quality of life.
Kanervisto M; Saarelainen S; Vasankari T; Jousilahti P; Heistaro S; Heliövaara M; Luukkaala T; Paavilainen E
Chron Respir Dis; 2010; 7(4):207-15. PubMed ID: 21084545
[TBL] [Abstract][Full Text] [Related]
3. Double-blind study of OM-85 in patients with chronic bronchitis or mild chronic obstructive pulmonary disease.
Solèr M; Mütterlein R; Cozma G;
Respiration; 2007; 74(1):26-32. PubMed ID: 16772707
[TBL] [Abstract][Full Text] [Related]
4. Impulse oscillometry may be of value in detecting early manifestations of COPD.
Frantz S; Nihlén U; Dencker M; Engström G; Löfdahl CG; Wollmer P
Respir Med; 2012 Aug; 106(8):1116-23. PubMed ID: 22613172
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.
Danielsson P; Ólafsdóttir IS; Benediktsdóttir B; Gíslason T; Janson C
Clin Respir J; 2012 Apr; 6(2):120-7. PubMed ID: 21651748
[TBL] [Abstract][Full Text] [Related]
6. Excretion patterns of pseudouridine and beta-aminoisobutyric acid in patients with tumours of the upper urinary tract.
Kvist E; Sjølin KE; Iversen J
Scand J Urol Nephrol; 1990; 24(4):287-92. PubMed ID: 2274753
[TBL] [Abstract][Full Text] [Related]
7. Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD.
Bolton CE; Broekhuizen R; Ionescu AA; Nixon LS; Wouters EF; Shale DJ; Schols AM
Thorax; 2007 Feb; 62(2):109-14. PubMed ID: 16928709
[TBL] [Abstract][Full Text] [Related]
8. The presence of emphysema does not affect the systemic bioactivity of inhaled fluticasone in severe chronic obstructive pulmonary disease.
Lee DK; Lipworth BJ
Br J Clin Pharmacol; 2004 Apr; 57(4):388-92. PubMed ID: 15025735
[TBL] [Abstract][Full Text] [Related]
9. [The change of concentration of endothelin derived from alveolar macrophages and in induced sputum in patients with chronic bronchitis].
Peng H; Chen P; Cai S
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jun; 24(6):351-4. PubMed ID: 11802988
[TBL] [Abstract][Full Text] [Related]
10. Exhaled breath condensate levels of 8-isoprostane, growth related oncogene alpha and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease.
Ko FW; Lau CY; Leung TF; Wong GW; Lam CW; Hui DS
Respir Med; 2006 Apr; 100(4):630-8. PubMed ID: 16213701
[TBL] [Abstract][Full Text] [Related]
11. The Obstructive Lung Disease in Northern Sweden Chronic Obstructive Pulmonary Disease Study: design, the first year participation and mortality.
Lindberg A; Lundbäck B
Clin Respir J; 2008 Oct; 2 Suppl 1():64-71. PubMed ID: 20298352
[TBL] [Abstract][Full Text] [Related]
12. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.
Tinkelman DG; Price DB; Nordyke RJ; Halbert RJ
J Asthma; 2006; 43(1):75-80. PubMed ID: 16448970
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of urinary and serum pseudouridine in diagnosis and monitoring of primary liver cancer.
Tu Z; Xu S; Wu M
Chin Med J (Engl); 1995 Mar; 108(3):204-8. PubMed ID: 7796629
[TBL] [Abstract][Full Text] [Related]
14. Impact of chronic obstructive pulmonary disease with pulmonary hypertension on both left ventricular systolic and diastolic performance.
Yilmaz R; Gencer M; Ceylan E; Demirbag R
J Am Soc Echocardiogr; 2005 Aug; 18(8):873-81. PubMed ID: 16084341
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease.
Ágh T; Inotai A; Mészáros Á
Respiration; 2011; 82(4):328-34. PubMed ID: 21454953
[TBL] [Abstract][Full Text] [Related]
16. [Risk factors of chronic obstructive pulmonary disease in patients with chronic bronchitis].
Xie G; Cheng X; Xu X
Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(22):1356-9. PubMed ID: 11930627
[TBL] [Abstract][Full Text] [Related]
17. [Higher levels of urokinase plasminogen activator system components in the airways of chronic obstructive pulmonary disease patients].
Xiao W; Tong WL; Ma DD
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Nov; 29(11):723-6. PubMed ID: 17327049
[TBL] [Abstract][Full Text] [Related]
18. Decreased histone deacetylase activity in chronic obstructive pulmonary disease.
Ito K; Ito M; Elliott WM; Cosio B; Caramori G; Kon OM; Barczyk A; Hayashi S; Adcock IM; Hogg JC; Barnes PJ
N Engl J Med; 2005 May; 352(19):1967-76. PubMed ID: 15888697
[TBL] [Abstract][Full Text] [Related]
19. There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a population study.
Bednarek M; Plywaczewski R; Jonczak L; Zielinski J
Respiration; 2005; 72(2):142-9. PubMed ID: 15824523
[TBL] [Abstract][Full Text] [Related]
20. [Living conditions for people with COPD].
Hem KG; Eide AH
Tidsskr Nor Laegeforen; 2009 Aug; 129(15):1465-8. PubMed ID: 19690596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
